Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LN016 sustained-release gel for postoperative analgesia after abdominal surgery
CTR20262500Phase 2Active
- Sponsor
- Shanghai Huiyong Pharmaceutical
- Start
- Jun 2026
- Modality
- Small Molecules, Hydrogel Systems → Drug Delivery Systems
- Countries
- 1
01
Overview
A Phase 2 trial of bupivacaine in postoperative pain, sponsored by Shanghai Huiyong Pharmaceutical. Started Jun 2026; status: active.
02
Drugs
bupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on CTR20262500.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20262500.